ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ZLAB Zai Lab Ltd

21.813
0.293 (1.36%)
15 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Zai Lab Ltd ZLAB 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.293 1.36% 21.813 09:00:00
개장가 저가 고가 종가 전일 종가
21.52 21.00 21.82 21.55 21.52
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/05/202402:22EDGAR2Form 144 - Report of proposed sale of securities
14/05/202420:30BWZai Lab Announces Acceptance of Supplemental Biologics..
13/05/202409:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
09/05/202405:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202405:09EDGAR2Form 8-K - Current report
09/05/202405:05BWZai Lab Announces First Quarter 2024 Financial Results and..
15/04/202420:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
11/04/202420:30BWZai Lab Statement on Executive Management Team’s Agreement..
02/04/202420:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
01/04/202420:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
27/03/202422:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
14/03/202408:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
07/03/202406:01BWZai Lab to Present Final Overall Survival (OS) Data from..
06/03/202421:30BWZai Lab Announces Participation in March Investor Conference
05/03/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202406:12EDGAR2Form 8-K - Current report
28/02/202406:05BWZai Lab Announces Full-Year 2023 Financial Results and..
09/02/202406:37EDGAR2Form 8-K - Current report
26/01/202406:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
11/01/202407:12BWZai Lab Announces The New England Journal of Medicine..
04/01/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202405:50EDGAR2Form 144 - Report of proposed sale of securities
04/01/202405:47EDGAR2Form 144 - Report of proposed sale of securities
04/01/202405:42EDGAR2Form 144 - Report of proposed sale of securities
23/12/202306:29EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
19/12/202321:30BWZai Lab Announces Participation in January Investor..
19/12/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
13/12/202313:10BWZai Lab Announces the First Listing of VYVGART®..
17/11/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202306:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:10EDGAR2Form 8-K - Current report
08/11/202306:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
04/11/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202304:20EDGAR2Form 144 - Report of proposed sale of securities
26/10/202320:30GLOBEZai Lab Announces Participation in November Investor..
18/10/202320:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
04/10/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/09/202320:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
08/09/202319:12EDGAR2Form 144 - Report of proposed sale of securities
30/08/202320:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
29/08/202320:38GLOBEZai Lab Announces Participation in September Investor..
22/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202305:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/08/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:07EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock